Investment Bank Cuts Price Target on Gen-Probe Stock

The bank cited a lack of apparent competitive bids to acquire Gen-Probe in dropping its price target to $75.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.